Search Results

Employers should consider the following 2024 updates to SECURE 2.0; the benefits will serve as a clear differentiator within an increasingly competitive and uncertain economy.

The aging of the population has stabilized employer plan numbers for people over 65.

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular weight-loss drug. Novo Nordisk says the efforts infringe on its patent.

Eighty-five percent of companies either currently use or plan to implement HIPAA-compliant AI features in their consumer directed healthcare accounts.

Offering comprehensive, seamless obesity and digestive health support is the best way for employers to address rising costs of both conditions while maximizing their ROI on GLP-1 drugs.

It's essential to connect the program to wider business initiatives (end of the year or open enrollment) and Include messages of support from the CEO to demonstrate the program's importance, recommends financial wellbeing provider nudge.

Per-employee spending for the other 90% has been flat since 2012.

Four million Americans will be turning 65 every year for the next four years, which is why employers need to communicate the in-service distribution option to employees, says Joseph Roop, president, Belmont Capital Advisors.